Healthy Livers, Healthy Lives at #EASLcongress 2024. Our symposium is talking about the global impact of liver diseases, featuring insights from WHO, discussions on public health threats like MASLD and MASH, and analysis of the economic burden. Don't miss out on this crucial

Prevalence of metALD in general population- 2-10 percent #easl ⁦AASLD⁩ ⁦Juan Pablo (JP) Arab, MD ⁩ ⁦Cheng Han Ng⁩ ⁦Daniel Huang⁩ ⁦Maja Thiele⁩

The 2024 Global status report on alcohol just released by the World Health Organization (WHO): 🔸2.6 million deaths are due to alcohol (4.7% of all). 🔸400 million people (7% population) live with alcohol use disorders. 🔸Europe and Africa have the highest alcohol consumption. t.ly/ocf7J

Congrats Pojsakorn Dan Danpanichkul, MD and Karn! #livertwitter • #MASLD and 🫀 are rising 🌎 • Highest mortality in obesity (+134 %) •Low + lower-middle-income countries accounted for 43 % of the global MASLD prevalence. 👉👉authors.elsevier.com/c/1jMMp5x4Wd~n3 Juan Pablo (JP) Arab, MD  Jeffrey V. Lazarus Mazen Noureddin, MD, MHSc

Tenemos el honor de presentarles a quienes han trabajado arduamente en la creación de un Programa Científico de excelencia para el Congreso ALEH 2024, el que puedes revisar en nuestra página web congresoaleh.com

Addictive disorders are increasingly impacting liver disease outcomes J Mellinger Lamia Haque edit this crucial CLD series on addiction and liver disease. A must read! Full series: journals.lww.com/cld/pages/coll… Sample content: journals.lww.com/cld/fulltext/2… journals.lww.com/cld/fulltext/2…

Massive series from ClinicalLiverDisease featuring great content featuring Juan Pablo (JP) Arab, MD  Luis Antonio Díaz, MD Ruben Hernaez Lorenzo Leggio Dr. Melissa Weimer jeanette tetrault edited by Jessica Mellinger Lamia Haque

Enforcing legal drinking ages, public education, and screening can reduce youth alcohol intake. ⚠️Early actions are needed to combat ALD in adolescents and young adults 🍷🚫 shorturl.at/eOVVt Karn Wijarnpreecha Suthat Liangpunsakul Juan Pablo (JP) Arab, MD  Luis Antonio Díaz, MD

What should be endpoints and what are the unmet needs in ALD & AUD?! Luis Antonio Díaz, MD Deepika Devuni MD Elliot Tapper Akash Roy Study of Alcohol-related LiVer disease in Europe Liver Fellow Network Suthat Liangpunsakul Vijay Shah Marco Arrese, MD Hanna Blaney, MD, MPH Doug Simonetto, MD Jeffrey V. Lazarus #livertwitter

Thrilled to share with you our review of esophageal disorders and liver disease. Congrats Francisco Idalsoaga MD Javier Chahuan Marco Arrese, MD Juan Pablo (JP) Arab, MD  ! Full access here: onlinelibrary.wiley.com/doi/10.1111/ap… #LiverTwitter

I am very grateful to have been able to collaborate in this The Lancet Seminar on Acute Liver Failure with Rakhi Maiwall Anand V Kulkarni Salvatore Piano Very important topic, hope you find it useful and informative 👉 Acute liver failure (ALF) is a life-threatening disorder

JUST PUBLISHED in Liver International "Racial and ethnic disparities in the natural history of alcohol-associated liver disease in the United States" onlinelibrary.wiley.com/doi/10.1111/li… Luis Antonio Díaz, MD Juan Pablo (JP) Arab, MD  Ramon Bataller Marco Arrese, MD Robert Wong, MD, MS, FAASLD, FACG #LiverTwitter

"Racial and ethnic disparities in the natural history of alcohol-associated liver disease in the United States" in Liver International Using data from NHANES, NIS and UNOS to assess the spectrum of ALD and try to understand disparities. Great effort led by Gustavo Ayares C. Luis Antonio Díaz, MD

Thank you, Professor Suthat Liangpunsakul for highlighting our recent study on the epidemiology of 🍺alcohol-related liver disease in adolescents and young adults. 🔗 rb.gy/rfqu8w Karn Wijarnpreecha Luis Antonio Díaz, MD Juan Pablo (JP) Arab, MD  Mazen Noureddin, MD, MHSc Dr.Bornie

📢 10-yrs Experience of the LATINDILI Network 468 idiosyncratic DILI cases from 10 countries. Increasing incidence of HILI and dietary supplements, w/high mortality rate. 🔓 shorturl.at/Rf2YL Thanks to the Spanish DILI registry for their support. ALEH Asociación Española para el Estudio del Hígado

We are busy preparing for the first United Nations General Assembly MASH side-event, 23 Sept 2024 - in NYC. We need a whole-of-society effort to end this public health threat. For ex food inequity + insecurity are MASLD and MASH risk factors: nature.com/articles/s4157… #LiverTwitter

Grand rounds at the UC San Diego Health with Dr. Rohit Loomba highlighting recent NEJM Tirzepatide for MASH F2-3 👉🏽 up to 62% MASH resolution and 55% at least 1 stage fibrosis improvement nejm.org/doi/full/10.10… #LiverTwitter AASLD

New Comment - Lazarus et al - Best buy interventions to address the burden of steatotic liver disease thelancet.com/journals/langa… #LiverTwitter #MASLD Jeffrey V. Lazarus

"Best buy interventions to address the burden of steatotic liver disease". Out Today in the The Lancet Gastroenterology & Hepatology thelancet.com/journals/langa… Join the discussion at the first United Nations General Assembly MASH side-event, 23 Sept 2024 in NYC: events.economist.com/custom-events/… #LiverTwitter

Happy to share our narrative review of the natural history of MASLD in The Lancet Gastroenterology & Hepatology Link: thelancet.com/journals/langa… Ying Shang Patrik Nasr Hannes Hegmar #LiverTwitter Karolinska Institutet